ICRP 123: Ca40 - dawki narządowe i współczynniki jakości
Źródło: ICRP Publication 123, Assessment of Radiation Exposure of Astronauts in Space, supplementary data, Annals of the ICRP 42(4), 2013, strony PDF: arkusz Ca40. Podpis w źródle: Supplementary data workbook P 123 JAICRP 42(4) DB of heavy ion.xls, sheet Ca40
Znormalizowana macierz danych ICRP 123 dla cząstki Ca40: energia, narząd lub wielkość efektywna, płeć fantomu, typ wielkości, jednostka i wartość. Dane obejmują współczynniki konwersji fluencji cząstek na dawkę pochłoniętą oraz średnie współczynniki jakości w geometrii izotropowej.
Źródłowe arkusze miały układ szeroki z wielopoziomowymi nagłówkami; import zapisano w układzie długim, aby można było filtrować po energii, narządzie, płci i typie wielkości.
Kolumny SwTDT/F, DT/F, QICRP60 i QNASA zachowują nazwy źródłowe z arkusza. Jednostka pGy cm2 lub pSv cm2 jest podana w kolumnie jednostka wartości.
Pokazano 4392 z 4392 wierszy.
| Cząstka | Symbol | Z | A | Energia | Jednostka energii | Narząd/tkanka albo wielkość | Płeć/fantom | Wielkość źródłowa | Opis wielkości | Jednostka wartości | Wartość |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 70.5 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 63.6 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 77.3 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6360 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7730 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 1 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 141 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 127 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 154 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12700 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 2 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 211 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 191 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 232 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19100 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23200 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 3 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 351 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 317 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 385 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31700 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38500 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 5 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 829 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 799 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 860 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.41 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 655 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 768 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 964 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26.7 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.81 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.17 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63200 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76600 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79.3 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11.2 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 931 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.7 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59.4 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.68 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 10 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1180 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1140 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1210 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11.4 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 0.9 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.95 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1150 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.121 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.113 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.126 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.133 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.133 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.119 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1330 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.127 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.13 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.316 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.193 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38.2 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.53 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.16 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.169 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13.5 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.218 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87800 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12.4 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1320 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 153 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.12 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.113 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.111 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61.5 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.165 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85.3 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.84 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.119 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.173 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.0957 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.117 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.112 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.148 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.138 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.263 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3 |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 14 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1720 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1680 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 1760 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.4 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.22 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2250 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2170 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.486 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.505 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.488 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.517 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.39 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.522 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1860 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.273 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.468 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.483 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.347 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.425 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.522 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.734 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.417 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.621 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58.8 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13.1 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.615 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.626 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33.2 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.24 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 175 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25.8 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.427 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.479 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2040 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 315 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.497 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.388 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.447 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.468 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.44 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.465 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.753 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.7 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.528 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.33 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.372 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.458 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.382 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.531 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.466 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.446 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.377 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.485 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0.81 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 0 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.1 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.1 |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2730 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2730 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 2730 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33.2 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5150 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4590 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.77 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.69 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.71 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.77 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.57 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.8 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3220 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.79 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.56 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.68 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.66 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.55 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.39 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.24 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.73 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.99 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.4 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24.7 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.16 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.47 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88.2 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.69 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 181000 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 217000 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 286 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 42.2 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.15 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.47 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3260 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 499 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.42 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.3 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.52 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.65 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.43 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.46 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 225 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.44 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 215 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20.5 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.45 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.8 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.43 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.39 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.22 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.42 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.57 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.6 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.56 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1.64 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3.02 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2.79 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.2 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60.2 |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 30 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 5540 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 5850 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 5240 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80.8 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34.5 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19900 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18100 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.83 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.42 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.45 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9.43 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.25 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10.2 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7100 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4.87 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.42 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.97 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.43 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.24 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22.6 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30.1 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.92 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17.3 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 233 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67.9 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 13.7 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16.4 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 407 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.6 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 279000 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 304000 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 625 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.41 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.19 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6710 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.79 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.14 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.78 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.6 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.93 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.32 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 836 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21.7 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 501 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14.4 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81.4 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.16 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.07 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.24 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5.39 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.81 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7.13 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6.7 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8.58 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19.3 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16.3 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3560 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3560 |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 11200 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 13300 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 9180 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 243 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75200 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 54400 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 44.6 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.8 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 40.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47.4 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.2 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17400 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41.4 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.1 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 25.5 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 649 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 277 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.7 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84.4 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8700 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 545 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 252000 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 256000 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1750 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 318 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15600 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2590 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 20.8 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 29.7 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36.1 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 26.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4930 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1940 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 394 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66.2 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 718 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22.2 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 16.6 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19.1 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.8 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31.2 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28.6 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 39.2 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64.3 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 245000 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 245000 |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 75 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 17100 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 21400 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 12800 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 821 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 954 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 1.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85000 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 161 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 154 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.4 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 140 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31200 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52.1 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96.6 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87.3 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 284 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 281 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.8 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 211 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2330 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1890 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 207 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 243 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30600 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8380 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 214000 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 214000 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3960 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1240 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68.1 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65.6 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30800 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8620 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69.9 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91.8 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.8 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83.2 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 12400 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 909 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6790 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2240 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3440 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43.3 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73.7 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49.7 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56.1 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89.3 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99.6 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98.8 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 297 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 198 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 245000 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 245000 |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ca40 | Ca-40 | 20 | 40 | 100 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 27700 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 33800 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 21600 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10100 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9870 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 189000 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 977 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 640 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 702 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 713 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 440 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 587 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60800 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 313 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 498 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 625 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 754 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 553 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 14600 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21700 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 380 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21900 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 23200 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 21800 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1500 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2510 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86600 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 48700 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 167000 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 167000 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 11800 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7250 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 347 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 355 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69100 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32800 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 353 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 374 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 431 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 530 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 384 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 425 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 27600 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 18900 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32700 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 10800 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17200 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 269 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 408 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 290 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 319 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 435 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 452 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 456 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 563 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 9750 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6640 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 186000 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 186000 |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 150 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 37600 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 42600 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 32600 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22200 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 22500 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 191000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 144000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6250 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8800 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 5200 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3800 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1350 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8760 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86100 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 946 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4420 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 7610 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4940 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3850 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72900 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1090 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 41400 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52900 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 47700 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19500 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32400 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85700 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 145000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 147000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 982 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83600 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49200 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 959 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1060 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1440 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2900 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1120 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 37100 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62400 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43900 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 19000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 32800 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 828 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1070 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.3 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 857 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 926 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2230 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1480 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1260 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.8 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 1850 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35700 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 30300 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.2 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.9 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 150000 |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 200 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 64200 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 64500 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 63800 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 46400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 49200 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 146000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25.3 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53900 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58300 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 45500 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66300 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 36200 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56300 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98300 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 3000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 35200 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 51300 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 24800 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28200 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99700 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 28800 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 56500 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97800 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92900 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 25 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43900 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 43800 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15500 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4850 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78800 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 6140 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 38400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 17200 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 15400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 52300 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 53300 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96600 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94800 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2900 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 8460 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 2920 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 3.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 4100 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 31400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 34700 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 33600 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.2 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 57400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85400 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76100 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.6 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 148000 |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 300 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 24.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99500 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 25.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.3 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96600 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89800 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94800 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98800 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91100 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87400 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 157000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99400 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75900 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95500 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 149000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 136000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 23 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84400 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98100 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87300 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 139000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70500 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84800 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85300 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88800 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.1 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94300 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94300 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 116000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.5 | |
| Ca40 | Ca-40 | 20 | 40 | 500 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 18.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 25.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95600 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99300 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.8 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98600 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.8 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 121000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 26.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 26.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93900 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.8 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91400 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96900 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.7 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94700 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 26.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 26.3 | |
| Ca40 | Ca-40 | 20 | 40 | 700 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 88000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 88600 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 87400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 14.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85100 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83900 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82900 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82500 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84300 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88700 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86100 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97600 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81600 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84300 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94100 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.4 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98600 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81600 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85500 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97800 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99900 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83800 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80900 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82500 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81700 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82300 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85100 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92500 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98500 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74300 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76500 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76500 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79400 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80100 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85100 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87100 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91900 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.4 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87200 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 24.5 | |
| Ca40 | Ca-40 | 20 | 40 | 1000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 71300 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 71700 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 70900 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92700 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85700 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67300 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71800 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73000 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62500 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77000 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61600 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63600 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67200 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62600 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77800 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 60100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66300 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76800 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77300 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80900 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82700 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82700 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92800 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68200 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69200 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62700 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62300 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86600 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81300 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66600 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69200 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62800 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69200 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69400 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75300 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81200 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58600 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63200 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 58900 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 62900 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63500 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65000 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65900 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75100 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96000 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96000 |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 2000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 72600 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 72800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 72500 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68700 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69400 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86900 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67100 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66300 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72900 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72900 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67100 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74400 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63400 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66400 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69300 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75900 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80300 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 61600 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72000 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78500 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77500 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81500 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94000 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69600 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64900 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83300 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64600 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66000 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72500 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66700 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71600 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70300 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76500 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.9 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81500 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78400 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 59300 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64100 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 63000 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 64800 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65000 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66200 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70700 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75700 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75700 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93700 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93700 |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 3000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 12.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 79200 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 79300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 79100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74200 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76000 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94400 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75000 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77700 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83500 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86500 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72000 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79600 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77700 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84000 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88400 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89000 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97700 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99800 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76000 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74600 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70000 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92700 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88400 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69700 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70400 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78800 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73600 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74200 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74700 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80600 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83200 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86500 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70600 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 66300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 65400 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69800 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74800 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76100 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78400 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 79200 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82900 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92300 |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.3 | |
| Ca40 | Ca-40 | 20 | 40 | 5000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 11.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 79400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 79400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 79400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94700 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84500 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71800 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71200 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83300 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71200 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71000 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 75900 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85200 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83700 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72200 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83900 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90300 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91500 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95000 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93700 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99800 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76300 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76500 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72900 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90500 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71900 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72700 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 73600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 72100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 68900 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 76700 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77800 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84300 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87200 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 71000 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 67600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 69500 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 70700 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 74700 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 78600 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84300 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81100 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91400 |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 10000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 89400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 90100 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 88600 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85200 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97500 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82600 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 91300 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90100 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85100 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87600 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92500 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83300 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84600 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88600 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81900 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85100 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 89500 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 90300 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83900 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 93300 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92800 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99900 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 99000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 86900 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87300 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77600 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 77800 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 85000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87200 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 82700 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84800 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 87000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83700 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 94100 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 95000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 97400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80300 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83200 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 81000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83400 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.4 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 83200 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 80600 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 84000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 88200 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 92300 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 96100 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.1 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23 | |
| Ca40 | Ca-40 | 20 | 40 | 20000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 110000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 119000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 98100 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 105000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 112000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 111000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 23.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 115000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 100000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 102000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 107000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.3 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 113000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 106000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 103000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 101000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.4 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 109000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 114000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 104000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.8 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 108000 |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 22 | |
| Ca40 | Ca-40 | 20 | 40 | 50000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 9.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 129000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Sex-averaged | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Male | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 131000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Female | SwTDT/F | wazony wspolczynnik dawki z naglowka zrodla SwTDT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Effective dose equivalent | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Red bone marrow | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Red bone marrow | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Red bone marrow | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Red bone marrow | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 122000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Red bone marrow | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Red bone marrow | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 2.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Breast | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 151000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Breast | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Breast | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Breast | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 137000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Breast | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Breast | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Colon | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Colon | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Colon | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Colon | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Colon | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Colon | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lungs | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 123000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lungs | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lungs | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lungs | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lungs | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lungs | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Stomach wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Stomach wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Stomach wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Stomach wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Stomach wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Stomach wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gonads | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gonads | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gonads | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gonads | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gonads | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gonads | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Liver | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Liver | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Liver | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Liver | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Liver | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Liver | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oesophagus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oesophagus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oesophagus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oesophagus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oesophagus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oesophagus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thyroid | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 120000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thyroid | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thyroid | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thyroid | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thyroid | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thyroid | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Urinary bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Urinary bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Urinary bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Urinary bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Urinary bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Urinary bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Endosteum (Bone surface) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Brain | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 124000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Brain | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Brain | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Brain | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Brain | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 19.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Brain | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Salivary glands | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 134000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Salivary glands | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Salivary glands | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Salivary glands | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Salivary glands | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Salivary glands | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Skin | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 141000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Skin | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Skin | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Skin | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 142000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Skin | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Skin | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Remainder tissues | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Remainder tissues | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Remainder tissues | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Remainder tissues | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Remainder tissues | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Remainder tissues | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Adrenals | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Adrenals | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Adrenals | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Adrenals | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 118000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Adrenals | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 10.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Adrenals | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 20.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Extrathoracic (ET) region | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gall bladder wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gall bladder wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gall bladder wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gall bladder wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 117000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gall bladder wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Gall bladder wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Heart wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Heart wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Heart wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Heart wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Heart wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Heart wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Kidneys | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 133000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Kidneys | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Kidneys | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Kidneys | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Kidneys | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Kidneys | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lymphatic nodes | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lymphatic nodes | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lymphatic nodes | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lymphatic nodes | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 130000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lymphatic nodes | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 14.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Lymphatic nodes | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Muscle | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Muscle | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Muscle | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Muscle | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Muscle | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Muscle | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oral mucosa | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 125000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oral mucosa | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 17.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oral mucosa | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.7 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oral mucosa | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oral mucosa | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 18.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Oral mucosa | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Pancreas | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Pancreas | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 9.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Pancreas | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Pancreas | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Pancreas | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Pancreas | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 135000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 127000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Prostate (male) / Uterus (female) | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Small intestine wall | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Small intestine wall | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 11.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Small intestine wall | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 4.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Small intestine wall | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Small intestine wall | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 12.6 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Small intestine wall | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.3 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Spleen | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 129000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Spleen | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 13.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Spleen | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.2 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Spleen | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 132000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Spleen | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Spleen | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 5.9 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thymus | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 131000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thymus | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 16 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thymus | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.1 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thymus | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 128000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thymus | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 15.8 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Thymus | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 6.4 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Eye lens | Male | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Eye lens | Male | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Eye lens | Male | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Eye lens | Female | DT/F | wspolczynnik dawki pochlonietej DT/F | pGy cm2 | 126000 |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Eye lens | Female | QICRP60 | sredni wspolczynnik jakosci Q wedlug ICRP 60 | 21 | |
| Ca40 | Ca-40 | 20 | 40 | 100000 | MeV/u | Eye lens | Female | QNASA | sredni wspolczynnik jakosci Q wedlug koncepcji NASA | 8.5 |